Pharmacological aspects of the neuroprotective effects of irreversible MAO-B inhibitors, selegiline and rasagiline, in Parkinson’s disease

Pharmacological aspects of the neuroprotective effects of irreversible MAO-B inhibitors, selegiline and rasagiline, in Parkinson’s disease

The era of MAO-B inhibitors dates back more than 50 years. It began with Kálmán Magyar’s outstanding discovery of the selective inhibitor, selegiline. This compound is still regarded as the gold standard of MAO-B inhibition, although newer drugs have also been introduced to the field. It was reveale...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Szökő Éva
Tábi Tamás
Riederer Peter
Vécsei László
Magyar Kálmán
Dokumentumtípus: Cikk
Megjelent: 2018
Sorozat:JOURNAL OF NEURAL TRANSMISSION 125 No. 11
doi:10.1007/s00702-018-1853-9

mtmt:3337072
Online Access:http://publicatio.bibl.u-szeged.hu/14290

Hasonló tételek

Hasonló tételek